STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-18
DOI
10.1038/s41598-020-70948-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transient Sox9 Expression Facilitates Progression to Castrate Resistant Prostate Cancer
- (2020) Mannan Nouri et al. CLINICAL CANCER RESEARCH
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Elimination of SOX2/OCT4-Associated Prostate Cancer Stem Cells Blocks Tumor Development and Enhances Therapeutic Response
- (2019) Prasanna Kumar Vaddi et al. Cancers
- Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
- (2019) Meghan A. Rice et al. Frontiers in Oncology
- Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
- (2019) Qin Feng et al. Frontiers in Oncology
- MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
- (2019) Sarmistha Talukdar et al. Cancers
- STAT3, stem cells, cancer stem cells and p63
- (2018) Michaela Galoczova et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Prostate Cancer Stem Cells: Current Understanding
- (2018) Sergej Skvortsov et al. STEM CELLS
- SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression
- (2018) Jinfang Zhang et al. DEVELOPMENTAL CELL
- Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
- (2018) Daksh Thaper et al. Scientific Reports
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium
- (2017) Leanne K. Archer et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy
- (2017) Ricardo Leão et al. UROLOGIA INTERNATIONALIS
- Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
- (2017) Verónica Cánovas et al. Oncotarget
- Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
- (2017) Giacomo Canesin et al. PLoS One
- The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer
- (2016) Giacomo Canesin et al. EUROPEAN UROLOGY
- Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
- (2016) Zilma Escobar et al. JOURNAL OF MEDICINAL CHEMISTRY
- CD133 does not enrich for the stem cell activity in vivo in adult mouse prostates
- (2016) Xing Wei et al. Stem Cell Research
- MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway
- (2015) Yun-Li Chang et al. Oncotarget
- Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
- (2015) Jeremy S. Frieling et al. Cancer Control
- Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer
- (2015) Zhiqiang Han et al. Oncotarget
- Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer
- (2014) VIVIANA CASTILLO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
- (2014) Nicholas Don-Doncow et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization
- (2014) G Canesin et al. ONCOGENE
- JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
- (2013) P. Kroon et al. CANCER RESEARCH
- Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133+Stem/Progenitor Cells to Battle Prostate Cancer
- (2013) Dong-Rong Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
- (2011) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells
- (2011) Rebecka Hellsten et al. PLoS One
- Genomic profiling of tumor initiating prostatospheres
- (2010) Maria Duhagon et al. BMC GENOMICS
- SUnSET, a nonradioactive method to monitor protein synthesis
- (2009) Enrico K Schmidt et al. NATURE METHODS
- Prostate cancer stem cells
- (2008) SH Lang et al. JOURNAL OF PATHOLOGY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
- (2008) Richard Birnie et al. GENOME BIOLOGY
- Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
- (2007) Rebecka Hellsten et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now